Immunotherapy

2019 Texas Oncology Clinical Educational Symposium

2019 Texas Oncology Clinical Educational Symposium

Clinical outcomes for advanced cancers continue to improve through the ide…

Expiration Date: 6/27/2020

Max Credits: 2.5

View Activity

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Clinical Advances in Hepatocellular Carcinoma Management – Rapid Response from Chicago

Hepatocellular carcinoma (HCC) is an aggressive tumor that is commonly dia…

Expiration Date: 6/10/2020

Max Credits: 1

View Activity

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Applying Checkpoint Inhibitors in NSCLC and SCLC: A Symposium at HEMONC Today New York

Lung cancer remains the leading cause of cancer death among both men and w…

Expiration Date: 5/12/2020

Max Credits: 0.75

View Activity

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

The Latest on the Checkpoint Inhibitor Revolution in Advanced Melanoma: Focus on Long-term Outcomes and Brain Metastases

For patients diagnosed with metastatic melanoma, the lifetime incidence of…

Expiration Date: 4/30/2020

Max Credits: 1

View Activity

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

Clinical Advances in Cutaneous T-cell Lymphoma: What You Need to Know About a Rare Malignancy

Cutaneous T-cell lymphoma (CTCL) is a rare and heterogeneous type of T-cel…

Expiration Date: 1/6/2020

Max Credits: 0.75

View Activity

Precision Decisions: Realistic Cases: A 63-Year-Old Man with a 60 Pack per Year Smoking History, Intermittent Gross Hematuria, and Clots in Urine

Precision Decisions: Realistic Cases: A 63-Year-Old Man with a 60 Pack per Year Smoking History, Intermittent Gross Hematuria, and Clots in Urine

The integration of immune checkpoint inhibitors into treatment algorithms …

Expiration Date: 5/30/2019

Max Credits: 0

View Activity

Immuno-Oncology Forum III: Focus on NSCLC

Immuno-Oncology Forum III: Focus on NSCLC

The rapid evolution and integration of immune checkpoint inhibitors into t…

Expiration Date: 2/28/2019

Max Credits: 0

View Activity

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

For many years, the mainstay of initial treatment for metastatic bladder c…

Expiration Date: 2/23/2019

Max Credits: 0

View Activity

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

Benefits and Challenges of Immunotherapy: An Interdisciplinary Perspective

The integration of immunotherapies into management strategies for the trea…

Expiration Date: 1/11/2020

Max Credits: 0.5

View Activity

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

Advances in immunology and the advent of immune checkpoint blockade inhibi…

Expiration Date: 4/2/2018

Max Credits: 0

View Activity